The Current Ratio as of November 2024 (TTM) for Acasti Pharma Inc. (ACST) is 7.86

According to Acasti Pharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.86. This represents a change of -45.79% compared to the average of 14.50 of the last 4 quarters.

Acasti Pharma Inc. (ACST) Historical Current Ratio (quarterly & annually)

How has ACST Current Ratio performed in the past?

The mean historical Current Ratio of Acasti Pharma Inc. over the last ten years is 10.40. The current 7.86 Current Ratio has changed 7.46% with respect to the historical average. Over the past ten years (40 quarters), ACST's Current Ratio was at its highest in in the March 2021 quarter at 39.50. The Current Ratio was at its lowest in in the September 2018 quarter at 0.56.

Acasti Pharma Inc. (ACST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Acasti Pharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acasti Pharma Inc. (ACST) Average Current Ratio

How has ACST Current Ratio performed in the past?

The current Current Ratio of Acasti Pharma Inc. (ACST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acasti Pharma Inc. (ACST) Current Ratio vs. Peers

How is ACST’s Current Ratio compared to its peers?

Acasti Pharma Inc.’s Current Ratio is greater than Tonix Pharmaceuticals Holding Corp. (3.33), greater than Jaguar Health, Inc. (1.84), less than Diffusion Pharmaceuticals Inc. (10.96), greater than iBio, Inc. (3.37), greater than Aridis Pharmaceuticals, Inc. (0.24), greater than Akari Therapeutics, Plc (0.29), greater than Aditxt, Inc. (0.09), greater than ABVC BioPharma, Inc. (0.34), less than Pulmatrix, Inc. (19.40), greater than Onconova Therapeutics, Inc. (1.93), greater than Catalyst Biosciences, Inc. (0), greater than Bio-Path Holdings, Inc. (0.86), greater than Moleculin Biotech, Inc. (2.08), greater than Advaxis, Inc. (0.30), greater than GeoVax Labs, Inc. (4.17), greater than Ocugen, Inc. (2.58),

Build a custom stock screener for Acasti Pharma Inc. (ACST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acasti Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acasti Pharma Inc. (ACST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acasti Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.